Episode 202: The Ethics of Oncology Data on Social Media

Social media is an innovative study recruitment and intervention tool, but what are the ethical considerations surrounding its data? ONS member Lisa Carter-Harris, PhD, APRN, ANP-C, FAAN, associate attending behavioral scientist at Memorial Sloan-Kettering Cancer Center in New York, NY, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about online health data, using social media for oncology clinical trials, and the ethical considerations surrounding all of it. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by April 10, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center’s Commission on Accreditation. Episode Notes Check out these resources from today’s episode: Complete this evaluation for free NCPD. Attend Carter-Harris’s session at ONS Congress® on April 30, 2022, or view it on demand and earn NCPD contact hours from May 23–June 30, 2022. Carter-Harris’s primer on Facebook targeted advertising for research recruitment Digital Health article: Using Social Media for Health Research: Methodological and Ethical Considerations for Recruitment and Intervention Delivery Oncology Nursing Forum article: Ethical Considerations When Using Social Media for Research ONS webinar: Offering Clinical Trials Can Make a Difference To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email [email protected].

Om Podcasten

Where ONS Voices Talk Cancer. Join oncology nurses as they sit down to discuss the topics important to nursing practice and treating patients with cancer.